✦ LIBER ✦

A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer

✍ Scribed by Munster, P N; Thurn, K T; Thomas, S; Raha, P; Lacevic, M; Miller, A; Melisko, M; Ismail-Khan, R; Rugo, H; Moasser, M

Book ID: 109838778
Publisher: Nature Publishing Group
Year: 2011
Tongue: English
Weight: 401 KB
Volume: 104
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.2011.156

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of the histone deacetyl

A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer

✍ Tripathy, D.; Thara, E. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 120 KB

A phase I-II study of the histone deacet

A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

✍ Tu, Yifan (author);Hershman, Dawn L. (author);Bhalla, Kapil (author);Fiskus, War 📂 Article 📅 2014 🏛 Springer New York LLC 🌐 English ⚖ 447 KB

A phase I-II study of the histone deacet

A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

✍ Tu, Yifan (author);Hershman, Dawn L. (author);Bhalla, Kapil (author);Fiskus, War 📂 Article 📅 2014 🏛 Springer New York LLC 🌐 English ⚖ 447 KB

Phase 1 clinical trial of the novel prot

Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination

✍ Michael Millward, Timothy Price, Amanda Townsend, Christopher Sweeney, Andrew Sp 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 688 KB

Phase 1 study of the histone deacetylase

Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes

✍ Garcia-Manero, G.; Yang, H.; Bueso-Ramos, C.; Ferrajoli, A.; Cortes, J.; Wierda, 📂 Article 📅 2008 🏛 American Society of Hematology 🌐 English ⚖ 795 KB

Phase II study of the histone deacetylas

Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia

✍ Kristie A. Blum; Anjani Advani; Louis Fernandez; Richard Van Der Jagt; Joseph Br 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB